Icahn School of Medicine at Mount Sinai
Mount Sinai - Twitter Mount Sinai - YouTube Mount Sinai - Facebook

Genetic Testing Lab

About Us

About Us

Contact Us Addresses
General Inquiries
Tel: 212-241-7518
Fax: 212-241-0139
Mailing
Mount Sinai Genetic Testing Laboratory
One Gustave L. Levy Place
Box 1497
New York, NY 10029
Shipping
Saturday
Mount Sinai Outreach/Genetics
1425 Madison Ave
8th Floor Room 872
New York NY 10029
Billing Inquiries
Tel: 212-241-8717
Fax: 212-876-7805
Shipping
Monday-Friday
Mount Sinai Genetic Testing Laboratory
Atran Laboratory Building, Room 2-25
1428 Madison Avenue
New York, NY  10029
 

 

Our laboratories include Biochemical Genetics, Cytogenetics and Cytogenomics, and Molecular Genetics. We are also an American Board of Medical Genetics (ABMG) training site for all three laboratory specialties, and it is our goal to facilitate the education and training of highly knowledgeable genetics professionals.

Biochemical Genetics Laboratory 

Our laboratory performs comprehensive Newborn Screening (NBS) confirmatory testing, including amino acids, organic acids and carnitine/acylcarnitine profiles. We also provide monitoring services on methylmalonic acid, orotic acid, succinylacetone and a panel of 6 amino acids for PKU and MSUD patients. Our lysosomal Fabry and Gaucher enzyme testing and Gaucher biomarker-Chitotriosidase activity provides laboratory support for the Lysosomal Storage Disorders program. We also perform Tay-Sachs and Sandhoff enzyme assays for carrier screening as well as enzymatic prenatal testing in conjunction with molecular testing for at risk families. We have been approved by NYS to provide Tamoxifen metabolites analysis for Estrogen Receptor (ER) positive breast cancer patients receiving Tamoxifen treatment. This assay is in run in conjunction with CYP2D6 genotype to allow personalized tamoxifen dosing requirements for breast cancer patients. We are the only clinical lab in the country offering such testing services. Our 5-aminolevulinic acid (ALA) and porphobiligogen (PBG) panel in urine and blood has also been also recently approved by NYS to provide biochemical diagnostic and monitoring services for acute porphyrias.

Cytogenetics and Cytogenomics 

Laboratory Our Cytogenetics laboratory has always led the way with the most recent diagnostic advances in cytogenetic testing. Members of our cytogenetics group have described many syndromes and cytogenetic abnormalities. We are a high volume academic laboratory that services the entire Mount Sinai community and beyond. For CVS, we developed a method to obtain preliminary results within hours of the procedure, in order to provide rapid screening for high risk pregnancies with common aneuploidies. Our prenatal aneuploidy FISH screen is reported within 24 business hours of receipt of the specimen in > 99% of cases. This is especially useful, as many of our patients are of advanced maternal age or have had abnormal screening results. We have also had success in working with very small specimens (less than 0.5 mg), when larger samples are not available.

In addition, our laboratory combines cytogenetic and molecular techniques including fluorescence in situ hybridization (FISH) and the latest microarray technologies for the detection of deletion and duplication syndromes. We routinely perform FISH and array comparative genomic hybridization (aCGH) on both pre – and postnatal specimens. It is our ultimate goal to help to significantly reduce the incidence of genomic disorders through offering enhanced prenatal screening to all of our patients.

Molecular Genetics Laboratory 

Our Molecular Genetics laboratory is at the forefront in performing population screening of inherited disorders. With our recognized expertise in disorders prevalent in the Ashkenazi Jewish population, we currently provide the most comprehensive Ashkenazi Jewish Prenatal Genetic Screening panel (screening for 18 diseases) in the United States. In addition, we perform prenatal testing for all 18 disorders on direct chorionic villus samples, and report results within 4-7 days of the receipt of the specimen. Our comprehensive prenatal analysis program includes maternal cell contamination studies and mutation analysis with specimen requirements of only 2-4 mg of direct CVS, ensuring that most at risk couples will receive a result in the first trimester of the pregnancy. We also perform pan-ethnic screening including cystic fibrosis, fragile X and SMA testing.

The Laboratory currently performs sequence analysis for several single gene disorders, including Roberts syndrome, Tay-Sachs disease, Niemann-Pick Disease (A+B) and Fabry disease. We offer a craniofacial disorders gene panel and a panel of genes that confer susceptibility to porphyria. We also offer pharmacogenetic testing, including the most comprehensive screen for Warfarin (coumadin) variations.